1Schmidt- Wolf IG, Lefterova P, Mehta BA, et al. Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells[J]. Exp Hematol,1993,21(13) :1 673-1 679
2Maki G. Ex vivo purging of stem cell autografts using cytotoxic cells[J]. J Hematother Stem Cell Res, 2001,10(4): 545- 551
3Linn YC, Lau LC, Hui KM. Generation of cytokine- induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts [J]. Br J Haematol,2002 ,116(1):78-86
9Ridolfi L,Ridolfi R,Riccobon A,et al. Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage Ⅲ and Ⅳ melanoma[J]. J Immunother, 2003,26(2):156-162
7[1]Lu PH, Negrin RS. A novel population of expanded human CD3 + CD56 + cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[J]. J Immunol, 1994, 153(4): 1687-1696.
8[2]Schmidt-Wolf GD, Negrin RS, Schmidt-Wolf IG. Activated T cells and cytokine-induced CD3 + CD56 + killer cells [ J ]. Ann Hematol, 1997, 74(2): 51-56.
9[3]Hoyle C, Bangs CD, Negrin RS, et al. Expansion of philadelphia chromosome-negative CD3 + CD56 + cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice [ J ]. Blood, 1998, 92(9): 3318-3327.
10[4]Margolin KA, Negrin RS, Forman SJ, et al. Cellular immunotherapy and autologous transplantation for hematologic malignancy[ J ].Immunol Rev, 1997, 157: 231-240.
4Jing-Ting Jiang, Chang-Ping Wu, Lu-Jun Chen, Xiao Zheng, Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu Province, China Yi-Bei Zhu, Jing Sun, Xue-Guang Zhang, Key Laboratory of Stem Cell of Jiangsu Province, Institute of Biotechnology, Key Laboratory of Clinical Immunology of Jiangsu Province, Soochow University, Suzhou 215123, Jiangsu Province, China Yue-Ping Shen, Wen-Xiang Wei, Department of Medicine, Soochow University, Suzhou 215123, Jiangsu Province, China Bin-Feng Lu, Department of Immunology, University of Pitts- burgh School of Medicine, Pittsburgh, PA 15261, United States.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients[J].World Journal of Gastroenterology,2010,16(48):6155-6162. 被引量：82
4Schmidt Wolf GD,Negrin RS,Schmidt Wolf IGH. Activated T cells and cytokine--induced CD3+ CD56+ killer cells[J]. J Ann Hematol,1997,74(2) :51--56.
5Schmidt Wolf IG,Finke S, Huhn D,et al. Phase Ⅰ clinical study applying autologous immunological effector cells transfected with the interleukin-- 2 gene in patients with metastatic renal cancer,colorectal cancer and lymphoma[J]. Br J Cancer, 1999, 81(6) : 1009--1016.
